These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28918915)

  • 61. Novel therapies for unresectable and metastatic melanoma.
    Karimkhani C; Reddy BY; Dellavalle RP; Sundararajan S
    BMJ; 2017 Nov; 359():j5174. PubMed ID: 29191943
    [No Abstract]   [Full Text] [Related]  

  • 62. Ipilimumab associated colitis: an IpiColitis case series at MedStar Georgetown University Hospital.
    Rastogi P; Sultan M; Charabaty AJ; Atkins MB; Mattar MC
    World J Gastroenterol; 2015 Apr; 21(14):4373-8. PubMed ID: 25892889
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ipilimumab for relapse after allogeneic transplantation.
    Baker H
    Lancet Oncol; 2016 Sep; 17(9):e374. PubMed ID: 27452141
    [No Abstract]   [Full Text] [Related]  

  • 64. The nephrotoxicity of immune checkpoint inhibitor-based combinations.
    El Rassy E; Bakouny Z; Yared F; Chelala DN; El Karak F; Ghosn M
    Eur J Cancer; 2018 Nov; 103():274-278. PubMed ID: 30196990
    [No Abstract]   [Full Text] [Related]  

  • 65. Acute cerebellitis after administration of nivolumab and ipilimumab for small cell lung cancer.
    Naito T; Osaki M; Ubano M; Kanzaki M; Uesaka Y
    Neurol Sci; 2018 Oct; 39(10):1791-1793. PubMed ID: 29948463
    [No Abstract]   [Full Text] [Related]  

  • 66. Ipilimumab-induced colitis in patients with metastatic melanoma.
    De Felice KM; Gupta A; Rakshit S; Khanna S; Kottschade LA; Finnes HD; Papadakis KA; Loftus EV; Raffals LE; Markovic SN
    Melanoma Res; 2015 Aug; 25(4):321-7. PubMed ID: 25933207
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Infliximab Therapy for Corticosteroid-Resistant Ipilimumab-Induced Colitis.
    Beniwal-Patel P; Matkowskyj K; Caldera F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):274. PubMed ID: 26405697
    [No Abstract]   [Full Text] [Related]  

  • 68. Ipilimumab-Induced Secondary Hypophysitis.
    Cheema A
    Endocr Pract; 2018 Sep; 24(9):854. PubMed ID: 29624100
    [No Abstract]   [Full Text] [Related]  

  • 69. Autoimmune hypophysitis.
    Ileana-Dumbrava E; Subbiah V
    Lancet Oncol; 2018 Feb; 19(2):e123. PubMed ID: 29413466
    [No Abstract]   [Full Text] [Related]  

  • 70. Ipilimumab-induced acute severe colitis treated by infliximab.
    Pagès C; Gornet JM; Monsel G; Allez M; Bertheau P; Bagot M; Lebbé C; Viguier M
    Melanoma Res; 2013 Jun; 23(3):227-30. PubMed ID: 23458760
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pituitary Dysfunction: A Case Series of Immune Checkpoint Inhibitor-Related Hypophysitis in an Emergency Department.
    Miller AH; Brock P; Jim Yeung SC
    Ann Emerg Med; 2016 Aug; 68(2):249-50. PubMed ID: 27451306
    [No Abstract]   [Full Text] [Related]  

  • 72. Rituximab-associated colitis.
    Barreiro Alonso E; Álvarez Álvarez A; Tojo González R; de la Coba Ortiz C
    Gastroenterol Hepatol; 2019 Apr; 42(4):251-252. PubMed ID: 29884483
    [No Abstract]   [Full Text] [Related]  

  • 73. [Treating metastatic melanoma: Risk management].
    Lebbe C; Robert C
    Ann Dermatol Venereol; 2017 Jan; 144(1):3-5. PubMed ID: 28063593
    [No Abstract]   [Full Text] [Related]  

  • 74. 64-Year-Old Man With Altered Mental Status.
    Schmidt TJ; Subat YW; Gallo De Moraes A
    Mayo Clin Proc; 2020 Sep; 95(9):e91-e96. PubMed ID: 32861350
    [No Abstract]   [Full Text] [Related]  

  • 75. Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities.
    Subudhi SK; Aparicio A; Gao J; Zurita AJ; Araujo JC; Logothetis CJ; Tahir SA; Korivi BR; Slack RS; Vence L; Emerson RO; Yusko E; Vignali M; Robins HS; Sun J; Allison JP; Sharma P
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11919-11924. PubMed ID: 27698113
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The cost of ipilimumab toxicity: a single-centre analysis.
    Yousaf N; Davidson M; Goode E; Thomas C; Hung R; Gore M; Larkin J
    Melanoma Res; 2015 Jun; 25(3):259-64. PubMed ID: 25860328
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Severe colitis while responding to ipilimumab in metastatic melanoma.
    Slingerland M; Nortier JW; Veenendaal RA; Kapiteijn E
    Acta Oncol; 2012 Jul; 51(6):805-7. PubMed ID: 22551308
    [No Abstract]   [Full Text] [Related]  

  • 78. The 2017 complete overhaul of adjuvant therapies for high-risk melanoma and its consequences for staging and management of melanoma patients.
    Eggermont AMM; Dummer R
    Eur J Cancer; 2017 Nov; 86():101-105. PubMed ID: 28968566
    [TBL] [Abstract][Full Text] [Related]  

  • 79. How should we diagnose and manage checkpoint inhibitor-associated colitis?
    Khan F; Funchain P; Bennett A; Hull TL; Shen B
    Cleve Clin J Med; 2018 Sep; 85(9):679-683. PubMed ID: 30192732
    [No Abstract]   [Full Text] [Related]  

  • 80. Ipilimumab-Induced Gastrointestinal Toxicities: A Management Algorithm.
    Klair JS; Girotra M; Hutchins LF; Caradine KD; Aduli F; Garcia-Saenz-de-Sicilia M
    Dig Dis Sci; 2016 Jul; 61(7):2132-9. PubMed ID: 26846115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.